Recently, AZGP1 was reported to be involved in the prognosis and various cancer progressions such as hepatocellular carcinoma (HCC) and pancreatic cancer; it regulates tumour progression through PTEN/Akt signalling and inhibits epithelial‐to‐mesenchymal transition (EMT) through TGFβ1‐ERK2 signalling.19, 20. This evidence concerns the gene AZGP1 and hepatocellular carcinoma.